(Q58020215)

1

0 references

Joan T. Gordon

2

0 references

Clark A. Rundell

3

0 references

Elisabeth Dequeker

Establishment of Stably EBV-Transformed Cell Lines from Residual Clinical Blood Samples for Use in Performance Evaluation and Quality Assurance in Molecular Genetic Testing

5

0 references

publication date

August 2008

0 references

published in

Human Mutation

0 references

volume

29

0 references

issue

8

0 references

page(s)

1063-1070

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

Quest for Controls in Molecular Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

Research network: EuroGentest--a European Network of Excellence aimed at harmonizing genetic testing services

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Developing a sustainable process to provide quality control materials for genetic testing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Design, development, validation, and use of synthetic nucleic acid controls for diagnostic purposes and application to cystic fibrosis testing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Genetic testing and quality control in diagnostic laboratories

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Quality control in molecular genetic testing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Laboratory standards and guidelines for population-based cystic fibrosis carrier screening

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

EuroGentest standing up to scrutiny--first year demonstrates good progress harmonizing community approaches

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Validation of cystic fibrosis mutation analysis using ABI 3130XL genetic analyzer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Towards quality assurance and harmonization of genetic testing services in the European Union

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

A comparative study of five technologically diverse CFTR testing platforms

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Quality control in mutation analysis: the European Molecular Genetics Quality Network (EMQN).

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20764

7 January 2021